GPR35 and schizophrenia: At last, KYNA has been shown to possess agonist activity at an orphan G-protein-coupled receptor (GPR35), which predominantly detected in immune cells and the gastrointestinal tract [30,32,164,165], but no data is available about a link between the GPR35 function and the pathophysiology of schizophrenia.